Biography and Research Information
OverviewAI-generated summary
Alina Viteri investigates clinical outcomes and treatment strategies for infectious diseases. Her work includes evaluating the effectiveness of vancomycin area-under-the-curve monitoring for patients with methicillin-susceptible *Staphylococcus aureus* bacteremia and assessing the impact of infectious diseases consultations on these outcomes. Viteri has also examined the use of newer agents, such as rezafungin, for invasive candidiasis and explored approaches to managing antibiotic resistance. Her research network includes collaborators from the University of Arkansas for Medical Sciences, such as Jacob M. Keck, Robert W. Bradsher, Juan Carlos Rico, and Ryan K. Dare. Viteri has a scholarly profile of 5 publications and 15 citations, with an h-index of 2.
Metrics
- h-index: 2
- Publications: 5
- Citations: 19
Selected Publications
-
“Dusting Off the Cobwebs”: Rethinking How We Use New Antibiotics (2025)
-
It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis (2025)
-
New Agents Are Coming, and So Is the Resistance (2024)
Collaboration Network
Top Collaborators
- New Agents Are Coming, and So Is the Resistance
- It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis
- “Dusting Off the Cobwebs”: Rethinking How We Use New Antibiotics
- 947. Evaluating the Outcomes of Infectious Diseases Consultation on methicillin susceptible <i>Staphylococcus aureus</i> Bacteremia
- 2567. Clinical Outcomes of Vancomycin Area-Under-the-Curve Monitoring: A Quasi-Experimental Study
- 947. Evaluating the Outcomes of Infectious Diseases Consultation on methicillin susceptible <i>Staphylococcus aureus</i> Bacteremia
- 2567. Clinical Outcomes of Vancomycin Area-Under-the-Curve Monitoring: A Quasi-Experimental Study
- 2567. Clinical Outcomes of Vancomycin Area-Under-the-Curve Monitoring: A Quasi-Experimental Study
- New Agents Are Coming, and So Is the Resistance
- New Agents Are Coming, and So Is the Resistance
- New Agents Are Coming, and So Is the Resistance
- New Agents Are Coming, and So Is the Resistance
- New Agents Are Coming, and So Is the Resistance
- It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis
- It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis
- It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis
- It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis
- It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis
Similar Researchers
Based on overlapping research topics